Offer - Urjas Oil for just ₹ 1 X
Cytosar 100 Injection 5 Ml is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Blood Cancer. Cytosar 100 Injection 5 Ml also has some secondary and off-label uses. These are listed below.
The correct dosage of Cytosar 100 Injection 5 Ml depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Cytosar 100 Injection 5 Ml as well, which are listed below. Such side effects of Cytosar 100 Injection 5 Ml normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Cytosar 100 Injection 5 Ml's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Cytosar 100 Injection 5 Ml's effects on the liver, heart and kidney are discussed below in the Cytosar 100 Injection 5 Ml related warnings section.
Other conditions have been mentioned below in the Cytosar 100 Injection 5 Ml contraindications section.
Drug interactions for Cytosar 100 Injection 5 Ml have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Cytosar 100 Injection 5 Ml is not safe while driving, and is is not addictive in nature.
Cytosar 100 Injection 5 Ml is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cytosar 100 Injection 5 Ml safe for pregnant women?
Cytosar (Pfz) shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Cytosar 100 Injection 5 Ml safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Cytosar (Pfz). So it is adviced to consult the doctor before using it.
What is the effect of Cytosar 100 Injection 5 Ml on the Kidneys?
Using Cytosar (Pfz) does not have any harmful effects on kidneys.
What is the effect of Cytosar 100 Injection 5 Ml on the Liver?
Cytosar (Pfz) can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Cytosar 100 Injection 5 Ml on the Heart?
Cytosar (Pfz) is not harmful for the heart.
Cytosar 100 Injection 5 Ml should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cytosar 100 Injection 5 Ml unless your doctor advises you to do so -
Is this Cytosar 100 Injection 5 Ml habit forming or addictive?
Cytosar 100 Injection 5 Ml is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Cytosar 100 Injection 5 Ml as you may feel sleepy.
Is it safe?
Cytosar 100 Injection 5 Ml is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Cytosar 100 Injection 5 Ml cannot treat any kind of mental disorder.
Interaction between Food and Cytosar 100 Injection 5 Ml
It is safe to take Cytosar 100 Injection 5 Ml with food.
Interaction between Alcohol and Cytosar 100 Injection 5 Ml
Due to lack of research, there is no information about the side effects of taking Cytosar 100 Injection 5 Ml with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 381-383
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 864-865
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depocyt® (cytarabine)